Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,158.00
Bid: 1,146.00
Ask: 1,148.00
Change: 22.00 (1.94%)
Spread: 2.00 (0.175%)
Open: 1,140.00
High: 1,158.00
Low: 1,120.00
Prev. Close: 1,136.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

19 Dec 2022 13:01

RNS Number : 2006K
Georgia Capital PLC
19 December 2022
 

London, 19 December 2022

 

 

 

Georgia Capital announces market purchase of shares for its Executive Equity Compensation Trust

 

Georgia Capital PLC (CGEO or the Group) was notified by Sanne Fiduciary Services Limited (Sanne), acting as trustee of the JSC Georgia Capital Executive Equity Compensation Trust (the Trust), that Sanne, through an independent broker, purchased in the market 100,000 CGEO ordinary shares with a nominal value of £0.01 each (Shares) at a price of £7.51 (rounded to two decimal points) per Share, traded on 16 December 2022 with a settlement date of 20 December 2022.

 

The Trust holds the Shares for the purpose of satisfying awards to be awarded to beneficiaries of the Trust. The executive directors and persons discharging managerial responsibility of the Group are potential beneficiaries under the Trust and are therefore treated as having an interest in such Shares. Upon settlement of the above transaction, the Trust will hold a total of 4,097,914 Shares, representing approximately 9.14% of CGEO's issued ordinary share capital.

 

Of the 4,097,914 Shares held by the Trust, 2,069,737 are allocated to existing awards.

 

 

Name of authorised official of issuer responsible for making notification: Link Company Matters Limited, Company Secretary

 

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a clinics and diagnostics business, (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20.0% equity stake in the water utility business and a 20.3% equity stake (at 30-Sep-22) in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge

 


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLKLFFLLLEFBK
Date   Source Headline
18th Jan 20225:32 pmRNSHolding(s) in Company
17th Jan 20226:17 pmRNSTransaction in Own Shares
14th Jan 20226:05 pmRNSTransaction in Own Shares
13th Jan 20225:16 pmRNSTransaction in Own Shares
12th Jan 20225:26 pmRNSTransaction in Own Shares
11th Jan 20225:55 pmRNSTransaction in Own Shares
10th Jan 20225:19 pmRNSTransaction in Own Shares
7th Jan 20225:28 pmRNSTransaction in Own Shares
7th Jan 20224:37 pmRNSDirector/PDMR Shareholding
6th Jan 20225:34 pmRNSTransaction in Own Shares
6th Jan 20229:57 amRNSPublication of Circular and Notice of GM
31st Dec 202110:28 amRNSDisposal
31st Dec 20217:00 amRNSTotal Voting Rights
30th Dec 20213:34 pmRNSCancellation of Treasury Shares
17th Dec 20214:21 pmRNSTransaction in Own Shares
15th Dec 20215:17 pmRNSTransaction in Own Shares
13th Dec 20215:40 pmRNSTransaction in Own Shares
6th Dec 20215:02 pmRNSTransaction in Own Shares
1st Dec 20215:56 pmRNSTransaction in Own Shares
1st Dec 20214:07 pmRNSTotal Voting Rights
1st Dec 20214:06 pmRNSCancellation of Treasury Shares
29th Nov 20215:45 pmRNSTransaction in Own Shares
26th Nov 20214:36 pmRNSTransaction in Own Shares
25th Nov 20215:32 pmRNSTransaction in Own Shares
19th Nov 20215:23 pmRNSTransaction in Own Shares
18th Nov 20215:36 pmRNSTransaction in Own Shares
16th Nov 20217:00 amRNS3rd Quarter Results
15th Nov 20215:57 pmRNSTransaction in Own Shares
12th Nov 20215:32 pmRNSTransaction in Own Shares
11th Nov 20215:48 pmRNSTransaction in Own Shares
11th Nov 20217:00 amRNSNotice of Results
5th Nov 20215:43 pmRNSCancellation of Treasury Shares
3rd Nov 20215:00 pmRNSTransaction in Own Shares
3rd Nov 202110:27 amRNSHolding(s) in Company
2nd Nov 20215:43 pmRNSTransaction in Own Shares
1st Nov 20214:51 pmRNSCancellation of Treasury Shares
1st Nov 20214:51 pmRNSTotal Voting Rights
29th Oct 20215:47 pmRNSTransaction in Own Shares
28th Oct 20215:34 pmRNSTransaction in Own Shares
26th Oct 20216:03 pmRNSTransaction in Own Shares
21st Oct 20215:54 pmRNSTransaction in Own Shares
18th Oct 20215:17 pmRNSTransaction in Own Shares
15th Oct 20215:07 pmRNSTransaction in Own Shares
14th Oct 20215:52 pmRNSTransaction in Own Shares
14th Oct 20217:00 amRNSTransaction in Own Shares
13th Oct 20211:04 pmRNSDirector Declaration
13th Oct 20217:00 amRNSMinority shareholders buyout in Retail (Pharmacy)
12th Oct 20215:51 pmRNSTransaction in Own Shares
11th Oct 20216:23 pmRNSCancellation of Treasury Shares
11th Oct 20216:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.